NS INVESTMENT

ns-investment-logo

NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company in the Republic of Korea. NSI was established in 2015 to independently manage venture capital funds and serve institutional investors in Korea. NSI is focused on meeting the financial objective of its fund investors. NSI seeks to link Korean investor capital with innovative companies beyond its domestic boarders and ultimately link entrepreneurs and science across continents.

#SimilarOrganizations #People #Financial #More

NS INVESTMENT

Founded:
2016-01-01

Status:
Active

Technology used in webpage:
Content Delivery Network Google Apps For Business JsDelivr PHP 7 JQuery CDN


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

akashi-therapeutics-logo

Akashi Therapeutics

Akashi Therapeutics is a clinical stage biopharmaceutical company.

Current Employees Featured

not_available_image

Jung-Seok Kang
Jung-Seok Kang Founder @ NS Investment
Founder
2015-01-01

Founder


not_available_image

Jung-Seok Kang

Investments List

Date Company Article Money raised
2022-08-25 Aktis Oncology NS Investment investment in Series A - Aktis Oncology 84 M USD
2022-05-09 Aspen Neuroscience NS Investment investment in Series B - Aspen Neuroscience 147.5 M USD
2022-02-03 Dewpoint Therapeutics NS Investment investment in Series C - Dewpoint Therapeutics 150 M USD
2022-01-10 Maze Therapeutics NS Investment investment in Venture Round - Maze Therapeutics 190 M USD
2021-11-02 Shoreline Biosciences NS Investment investment in Series B - Shoreline Biosciences 140 M USD
2021-10-21 ReCode Therapeutics NS Investment investment in Series B - ReCode Therapeutics 80 M USD
2021-08-18 Immunitas Therapeutics NS Investment investment in Series B - Immunitas Therapeutics 58 M USD
2021-08-04 Sonoma BioTherapeutics NS Investment investment in Series B - Sonoma BioTherapeutics 265 M USD
2020-04-23 Accent Therapeutics NS Investment investment in Series B - Accent Therapeutics 63 M USD
2020-03-11 Silverback Therapeutics NS Investment investment in Series B - Silverback Therapeutics 78.5 M USD

More informations about "NS Investment" on Search Engine